These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7617005)

  • 21. [Drugs, agranulocytosis and aplastic anemia].
    Lunde PK; Baksaas I
    Tidsskr Nor Laegeforen; 1986 Nov; 106(31):2639-41. PubMed ID: 3810581
    [No Abstract]   [Full Text] [Related]  

  • 22. Aplastic anemia associated with ticlopidine.
    Shapiro CM; Walk D
    Neurology; 1996 Jul; 47(1):300. PubMed ID: 8710103
    [No Abstract]   [Full Text] [Related]  

  • 23. [Agranulocytosis and aplastic anemia induced by drugs].
    Laporte JR
    Med Clin (Barc); 1987 Apr; 88(13):555-8. PubMed ID: 3295412
    [No Abstract]   [Full Text] [Related]  

  • 24. Severe normochrome and normocytic anemia after 19 months on ticlopidine.
    Finsterer J
    J Neuropsychiatry Clin Neurosci; 1999; 11(1):118-9. PubMed ID: 9990572
    [No Abstract]   [Full Text] [Related]  

  • 25. The design of a study of the drug etiology of agranulocytosis and aplastic anemia. A report from the International Agranulocytosis and Aplastic Anemia Study.
    Eur J Clin Pharmacol; 1983; 24(6):833-6. PubMed ID: 6884419
    [No Abstract]   [Full Text] [Related]  

  • 26. Ticlopidine-induced myelosuppression spontaneously remitted after five years: a possible link with amlodipine coadministration.
    Girtovitis F; Ntaios G; Baltatzi M; Kaiafa G; Ioannidis G; Chatzinikolaou A; Hatzitolios A; Papadopoulos A
    Intern Med J; 2009 May; 39(5):342-3. PubMed ID: 19545246
    [No Abstract]   [Full Text] [Related]  

  • 27. Aplastic anemia with ticlopidine therapy in two Chinese patients.
    Dunn P
    Ann Pharmacother; 1996 May; 30(5):547. PubMed ID: 8740343
    [No Abstract]   [Full Text] [Related]  

  • 28. Agranulocytosis and bone marrow aplasia induced by second-line drugs for rheumatoid arthritis. Treatment with granulocyte colony-stimulating factor.
    Sayag-Boukris V; Ziza JM; Brice P; Wechsler B
    Rev Rhum Engl Ed; 1997 Jan; 64(1):66. PubMed ID: 9051866
    [No Abstract]   [Full Text] [Related]  

  • 29. A randomized trial comparing ticlopidine hydrochloride with indobufen for the prevention of stroke in high-risk patients (TISS Study). Ticlopidine Indobufen Stroke Study.
    Bergamasco B; Benna P; Carolei A; Rasura M; Rudelli G; Fieschi C
    Funct Neurol; 1997; 12(1):33-43. PubMed ID: 9127122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ticlopidine and severe aplastic anemia.
    Rodriguez JN; Fernandez-Jurado A; Dieguez JC; Amian A; Prados D
    Am J Hematol; 1994 Dec; 47(4):332. PubMed ID: 7977309
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hemopathies caused by drugs in children: aplastic anemia, agranulocytosis, megaloblastic anemia].
    Masera G; Baronciani D; Conti A; Jankovic M; Uderzo C
    Minerva Pediatr; 1978 Sep; 30(18):1463-72. PubMed ID: 703709
    [No Abstract]   [Full Text] [Related]  

  • 32. [Bone marrow aplasia associated with ticlopidine treatment in a patient with idiopathic hypothyroidism].
    Pioda GB; Del Favero A; Rambotti P
    Clin Ter; 1989 Sep; 130(6):337-40. PubMed ID: 2530035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calcium dobesilate-induced agranulocytosis.
    Duggal L; Thukral R; Kumar S
    J Assoc Physicians India; 2005 Apr; 53():320-1. PubMed ID: 15987021
    [No Abstract]   [Full Text] [Related]  

  • 34. Ticlopidine for the prevention of thromboembolic stroke.
    Cowan S
    Axone; 1992 Dec; 14(2):58-9. PubMed ID: 1493112
    [No Abstract]   [Full Text] [Related]  

  • 35. [Agranulocytosis during a treatment with nitrendipine and ticlopidine].
    Lagier C; Vial T; Rabilloud M; Evreux JC
    Therapie; 1991; 46(2):169-70. PubMed ID: 2053096
    [No Abstract]   [Full Text] [Related]  

  • 36. [Agranulocytosis caused by ticlopidine].
    del Rey Moreno J; López Cortés LF; Gómez Mateos JM; Lozano de León F
    Neurologia; 1992 May; 7(5):121-2. PubMed ID: 1389293
    [No Abstract]   [Full Text] [Related]  

  • 37. [Drug-induced agranulocytosis: clinical study of 19 cases].
    Márquez JA; Pardo C; Amutio E; Cortés C; Piñán MA; Alvarez C
    Sangre (Barc); 1998 Oct; 43(5):436-8. PubMed ID: 9868339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cytopenias caused by hypoglycemic sulfonamides].
    Traissac FJ; Dangoumau J
    Journ Annu Diabetol Hotel Dieu; 1968; 9():197-212. PubMed ID: 4917931
    [No Abstract]   [Full Text] [Related]  

  • 39. Ticlopidine approved for stroke prevention.
    Clin Pharm; 1992 Feb; 11(2):99. PubMed ID: 1551303
    [No Abstract]   [Full Text] [Related]  

  • 40. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group.
    Hass WK; Easton JD; Adams HP; Pryse-Phillips W; Molony BA; Anderson S; Kamm B
    N Engl J Med; 1989 Aug; 321(8):501-7. PubMed ID: 2761587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.